NASDAQ:PRSPPerspecta Stock Price, Forecast & News

Perspecta's stock was trading at $20.45 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, PRSP shares have decreased by 11.7% and is now trading at $18.06. View which stocks have been mosted impacted by Coronavirus.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Perspecta in the last year. There are currently 1 sell rating and 5 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Perspecta.

Perspecta is scheduled to release its next quarterly earnings announcement on Thursday, June 4th 2020. View our earnings forecast for Perspecta.

Perspecta Inc (NASDAQ:PRSP) announced its quarterly earnings results on Wednesday, February, 12th. The company reported $0.55 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.51 by $0.04. The company earned $1.13 billion during the quarter, compared to analyst estimates of $1.11 billion. The company's revenue for the quarter was up 4.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.47 EPS. View Perspecta's earnings history.

Perspecta declared a quarterly dividend on Friday, February 14th. Investors of record on Tuesday, March 3rd will be paid a dividend of $0.06 per share on Wednesday, April 15th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 1.33%. The ex-dividend date of this dividend is Monday, March 2nd. View Perspecta's dividend history.

Perspecta updated its FY20 earnings guidance on Wednesday, February, 12th. The company provided EPS guidance of $2.12-2.18 for the period, compared to the Thomson Reuters consensus estimate of $2.13. The company issued revenue guidance of $4.45-4.50 billion, compared to the consensus revenue estimate of $4.48 billion.

6 brokerages have issued twelve-month price targets for Perspecta's stock. Their forecasts range from $18.50 to $28.00. On average, they anticipate Perspecta's stock price to reach $21.90 in the next twelve months. This suggests a possible upside of 21.3% from the stock's current price. View analysts' price targets for Perspecta.

Headlines about PRSP stock have been trending very negative recently, according to InfoTrie Sentiment Analysis. The research firm ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Perspecta earned a news sentiment score of -3.3 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near future. View the latest news aboutPerspecta.

Based on aggregate information from My MarketBeat watchlists, some companies that other Perspecta investors own include DXC Technology (DXC), Alibaba Group (BABA), Cisco Systems (CSCO), CVS Health (CVS), Honeywell International (HON), Home Depot (HD), AT&T (T), Verizon Communications (VZ), Thermo Fisher Scientific (TMO) and Procter & Gamble (PG).

Perspecta trades on the NASDAQ under the ticker symbol "PRSP."

Shares of PRSP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PRSP stock can currently be purchased for approximately $18.06.

Perspecta has a market capitalization of $2.92 billion.  View additional information about Perspecta.